Found "Public health policy": 1,085 results
Sort by
Relevance

A situational assessment for the establishment of a Southeast Asia Center for Infectious Disease Control (SEACID)

COVID-19 has shown that irresepctive of national borders, the infectious disease brings multi-dimensional challenges requiring concerted global and regional efforts to address it. In contrast to the European Union and the African Union, the Association of Southeast Asian Nations (ASEAN), the regional cooperation body in Southeast Asia, has had no e

Preferences for COVID-19 Contact Tracing in the WHO SEARO Region: A Discrete Choice Experiment

HITAP is now a member of the Global Outbreak Alert and Response Network (GOARN), which is a network of “250 technical institutions and networks globally that respond to acute public health events with the deployment of staff and resources to affected countries”, coordinated by WHO. As part of this collaboration, HITAP and NUS are conducting a s

Document review for M&E of COVID-19 vaccination programmes

This is a scoping review for Monitoring and Evaluation (M&E) framework of vaccination programme and indicators used in national vaccination programmes. This review synthesizes approaches and lessons to inform development of future frameworks. This work is part of the overarching post-covid-19 vaccination programme. More on this project: Monito

Economic Evaluation on Screening Strategies and Treatment Options for Postmenopausal Osteoporosis (in Thai language)

This cost-utility analysis was conducted as the result of a request from the Subcommittee for Development of the NLEM to provide information on the long-term effectiveness and cost-effectiveness of the screening of osteoporosis and its medical management. This information was then used to inform the Subcommittee regarding the selection of osteoporo

4th HTAsiaLink Newsletter: Communicating HTA

In this issue, the main article will focused on how HTA units in the Asian-Pacific region communicate with their stakeholders in order to push forward their research result. Secondly, we recently greet our two new members, HealthPact (Australia) and Department of Health (the Philippines), therefo

19th HTAsiaLink Newsletter: Highlights from the 11th HTAsiaLink Annual Conference in Malaysia

Details: The 11th HTAsiaLink Annual Conference took place in Putrajaya Malaysia, centered around the theme “Reshaping and Reshifting HTA in Navigating the Future Landscape”. Key discussions revolved around accelerating access to technologies, evaluating public health interventions and addressing ch

Mortality Attributable to Seasonal Influenza A and B Infections in Thailand, 2005–2009: A Longitudinal Study (2015)

Ben S. Cooper, Surachai Kotirum, Wantanee Kulpeng, Naiyana Praditsitthikorn, Malinee Chittaganpitch, Direk Limmathurotsakul, Nicholas P. J. Day, Richard Coker, Yot Teerawattananon, and Aronrag Meeyai* * Correspondence to Dr. Aronrag Meeyai, Department of Epidemiology, Faculty of Public Health, Mahi

Operationalising Regional Cooperation for Infectious Disease Control: A Scoping Review of Regional Disease Control Bodies and Networks

Abstract Background The rapid spread of the coronavirus disease 2019 (COVID-19) pandemic demonstrates the value of regional cooperation in infectious disease prevention and control. We explored the literature on regional infectious disease control bodies, to identify lessons, barriers and enable

Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance

The Thai government implemented COVID-19 booster vaccines to prevent morbidity and mortality during the spreading of the Omicron variant. However, little is known about which types of vaccine should be invested in as the booster dose for the Thai population. This study aims to investigate the most c

Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients

Systemic sclerosis (SSc) patients often become refractory to proton pump inhibitors (PPI)—a standard treatment for gastroesophageal reflux disease (GERD)—and intolerant to PPI in combination with domperidone. PPI with alginic acid is an alternative treatment option, but alginic acid is costly. We
10 / Page